Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
API
0
FDF
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate
2. 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole
3. Allegro
4. Frova
5. Frovatriptan
6. Frovelan
7. Sb 209509
8. Vml-251
9. Vml251
1. 158930-17-7
2. Frovatriptan Succinate Hydrate
3. Frovatriptan Succinate Monohydrate
4. Frovatriptan Succinate [usan]
5. Frovelan
6. Migard
7. Vml 251
8. Sb 209509-ax
9. D28j6w18hy
10. Sb 209509 Ax
11. Nsc-760422
12. Ncgc00183880-01
13. Butanedioic Acid;(6r)-6-(methylamino)-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate
14. (+)-(r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide Butanedioate (1:1), Monohydrate
15. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate
16. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), Monohydrate
17. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide, Hydrate (1:1:1)
18. Frovatriptan Succinate (usan)
19. Frovatriptan (succinate Hydrate)
20. (r)-3-(methylamino)-2,3,4,9-tetrahydro-1h-carbazole-6-carboxamide Succinate Hydrate
21. Butanedioic Acid,(6r)-6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate
22. Unii-d28j6w18hy
23. Frova (tn)
24. Dsstox_cid_28982
25. Dsstox_rid_83247
26. Dsstox_gsid_49056
27. Schembl2321442
28. Chembl2138684
29. Dtxsid2049056
30. Hy-b1658a
31. Tox21_113606
32. Akos030241886
33. Frovatriptan Succinate [mart.]
34. Frovatriptan Succinate [usp-rs]
35. Nsc 760422
36. 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, Butanedioate (1:1), Monohydrate
37. Frovatriptan Succinate [orange Book]
38. Cas-158930-17-7
39. Cs-0021309
40. D04264
41. Frovatriptan Succinate Monohydrate [mi]
42. Frovatriptan Succinate Monohydrate [who-dd]
43. Frovatriptan Succinate Monohydrate, >=97% (hplc)
44. J-009548
45. Q27276007
46. Frovatriptan Succinate, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 379.4 g/mol |
---|---|
Molecular Formula | C18H25N3O6 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 379.17433553 g/mol |
Monoisotopic Mass | 379.17433553 g/mol |
Topological Polar Surface Area | 147 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 426 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A FROVATRIPTAN SUCCINATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FROVATRIPTAN SUCCINATE, including repackagers and relabelers. The FDA regulates FROVATRIPTAN SUCCINATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FROVATRIPTAN SUCCINATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of FROVATRIPTAN SUCCINATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A FROVATRIPTAN SUCCINATE supplier is an individual or a company that provides FROVATRIPTAN SUCCINATE active pharmaceutical ingredient (API) or FROVATRIPTAN SUCCINATE finished formulations upon request. The FROVATRIPTAN SUCCINATE suppliers may include FROVATRIPTAN SUCCINATE API manufacturers, exporters, distributors and traders.
click here to find a list of FROVATRIPTAN SUCCINATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A FROVATRIPTAN SUCCINATE DMF (Drug Master File) is a document detailing the whole manufacturing process of FROVATRIPTAN SUCCINATE active pharmaceutical ingredient (API) in detail. Different forms of FROVATRIPTAN SUCCINATE DMFs exist exist since differing nations have different regulations, such as FROVATRIPTAN SUCCINATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A FROVATRIPTAN SUCCINATE DMF submitted to regulatory agencies in the US is known as a USDMF. FROVATRIPTAN SUCCINATE USDMF includes data on FROVATRIPTAN SUCCINATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FROVATRIPTAN SUCCINATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of FROVATRIPTAN SUCCINATE suppliers with USDMF on PharmaCompass.
A FROVATRIPTAN SUCCINATE written confirmation (FROVATRIPTAN SUCCINATE WC) is an official document issued by a regulatory agency to a FROVATRIPTAN SUCCINATE manufacturer, verifying that the manufacturing facility of a FROVATRIPTAN SUCCINATE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting FROVATRIPTAN SUCCINATE APIs or FROVATRIPTAN SUCCINATE finished pharmaceutical products to another nation, regulatory agencies frequently require a FROVATRIPTAN SUCCINATE WC (written confirmation) as part of the regulatory process.
click here to find a list of FROVATRIPTAN SUCCINATE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FROVATRIPTAN SUCCINATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for FROVATRIPTAN SUCCINATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture FROVATRIPTAN SUCCINATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain FROVATRIPTAN SUCCINATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FROVATRIPTAN SUCCINATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of FROVATRIPTAN SUCCINATE suppliers with NDC on PharmaCompass.
FROVATRIPTAN SUCCINATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of FROVATRIPTAN SUCCINATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FROVATRIPTAN SUCCINATE GMP manufacturer or FROVATRIPTAN SUCCINATE GMP API supplier for your needs.
A FROVATRIPTAN SUCCINATE CoA (Certificate of Analysis) is a formal document that attests to FROVATRIPTAN SUCCINATE's compliance with FROVATRIPTAN SUCCINATE specifications and serves as a tool for batch-level quality control.
FROVATRIPTAN SUCCINATE CoA mostly includes findings from lab analyses of a specific batch. For each FROVATRIPTAN SUCCINATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
FROVATRIPTAN SUCCINATE may be tested according to a variety of international standards, such as European Pharmacopoeia (FROVATRIPTAN SUCCINATE EP), FROVATRIPTAN SUCCINATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FROVATRIPTAN SUCCINATE USP).
LOOKING FOR A SUPPLIER?